MTHFD2 and breast carcinoma: Further in silico and in vitro validation in cultured breast cancer cells as well as in clinical breast cancer samples, indicated one of these genes, MTHFD2 (methylenetetrahydrofolate dehydrogenase 2), as a potential drug target to block breast cancer cell migration and invasion.